BlackRock Inc. - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 14 filers reported holding TRANSCODE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$469
-95.6%
1,385
-91.2%
0.00%
Q4 2022$10,551
-37.9%
15,678
+2.2%
0.00%
Q3 2022$17,000
-15.0%
15,334
-2.7%
0.00%
Q2 2022$20,000
-56.5%
15,764
-1.6%
0.00%
Q1 2022$46,000
+7.0%
16,022
-4.6%
0.00%
Q4 2021$43,000
-12.2%
16,796
+2.6%
0.00%
Q3 2021$49,00016,3660.00%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders